StrainX Bioworks

Active#50 worldwide · Alternative proteins

Estimated valuation · Alternative proteins · India

Develops food and nutrition ingredients through synthetic biology and precision fermentation, starting with alternative proteins, from a production facility in Bhopal.

Food & agriculture›Alternative proteins strainx.in

HQIndia

Last roundSeries A · May 2026

Estimated valuation

AI · Alternative proteins ranking (worldwide)

≈ USD 67MUSD 34–130M · Tens of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series A · USD 13M · May 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Alternative proteins · worldwide	Top 50	#50	Edition 0 · Oct 2026	28 Feb 2027

Rank historyOct 2026 · #50 Alternative proteinsFirst edition: no movements yet.

Funding history

Date	Round	Amount	Type	Investors
May 2026	Series A	USD 13M	Equity	Prime Venture Partners, Leo Capital, Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of StrainX Bioworks as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $67MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back StrainX Bioworks whether or not it has agreed: your intention joins the pool on StrainX Bioworks, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back StrainX Bioworks Or back food & agriculture in India

Pool on StrainX BioworksBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run StrainX Bioworks?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in alternative proteins

Full alternative proteins ranking →

Cauldron#49AustraliaTens of M$Meatly#48United KingdomTens of M$Guoke Xinglian#47ChinaTens of M$Imagindairy#46IsraelTens of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.